Redwood Pharma AB

Redwood Pharma AB was a Swedish pharmaceutical company founded in 2012 in Stockholm, dedicated to developing ophthalmic drugs using the IntelliGel® controlled-release platform. Its main products were RP101 (eye drops for severe chronic dry eye in post-menopausal women) and RP501 (smart hydrogel for mild dry eye). Note: the company declared bankruptcy in July 2024, having not found a viable solution to its financial situation.